Monitoring of drug safety 由 B. K. Romanov, S. V. Glagolev, V. A. Polivanov, M. V. Leonova

获取全文

Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022 由 A. V. Matveev, S. V. Glagolev, K. N. Koryanova, D. A. Sychev

获取全文

Typical pharmacovigilance system master file (PSMF) 由 B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov

获取全文

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results 由 Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, S. V. Glagolev

获取全文

Guidelines for the planning and implementation of pharmacovigilance systems audit 由 S. V. Glagolev, Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin

获取全文

Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice 由 A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov

获取全文

Standard form of a periodic safety update report 由 B. R. Romanov, R. N. Alyautdin, M. A. Darmostukova, S. V. Glagolev, V. A. Polivanov

获取全文

Preparation of a periodic safety update report 由 B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, A. E. Krasheninnikov

获取全文

Perfection of management principles by the safety signals of medicinal products 由 B. K. Romanov, V. K. Lepakhin, E. O. Zhuravleva, A. V. Astakhova, S. V. Glagolev, V. A. Polivanov

获取全文

Safety issues of monoclonal antibodies used in rheumatology 由 A. V. Philippova, A. S. Kolbin, E. V. Verbitskaya, S. V. Glagolev, V. A. Polivanov, V. I. Mazurov, R. R. Samigullina

获取全文

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease 由 N. A. Shatalova, D. A. Sychev, K. B. Mirzaev, A. I. Kochetkov, E. Yu. Ebzeeva, V. B. Dashabylova, P. O. Bochkov, S. N. Tuchkova, S. V. Glagolev

获取全文

ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS 由 N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov

获取全文

Analysis of spontaneous reports of adverse reactions, developed in the use of drugs during pregnancy 由 E. O. Zhuravleva, N. Yu. Velts, K. E. Zatolochina, S. V. Glagolev, V. A. Polivanov, M. A. Darmostukova, V. K. Lepakhin, B. K. Romanov, R. N. Alyautdin

获取全文

Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thro... 由 l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev

获取全文

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review 由 A. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, A. V. Matveev, V. I. Vechorko, O. V. Averkov, S. V. Glagolev, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, D. A. Sychev

获取全文

Drug Safety for Children — International Monitoring Data for 50 Years 由 B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, G. O. Dibirova, N. B. Dmitrieva, I. B. Zhukova, E. V. Kalinina, A. V. Kirillova, N. M. Kiseleva, G. V. Kukushkin, T. I. Leonteva, M. L. Maximov, E. V. Markina, S. E. Mileshina, D. E. Yurov

获取全文